Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cong Li
Observed name:
C.‐Y. Li
Institution:
Abbisko Therapeutics Co., Ltd. (China)
Observed institutions:
Sichuan University,
West China Medical Center of Sichuan University,
Chinese PLA General Hospital,
West China Hospital of Sichuan University,
Chinese People's Liberation Army,
Abbisko Therapeutics Co., Ltd. (China),
Inner Mongolia Medical University
show all 7
ORCID:
0000-0003-1128-8460
Observed ORCID:
0000-0003-1128-8460
OpenAlex ID:
A5102957151
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B
2023
·
Na Sang
, Xi Zhong
, et al.
·
MedComm
·
17
PDF
Molecular mechanisms of Lycoris aurea agglutinin‐induced apoptosis and G2/M cell cycle arrest in human lung adenocarcinoma A549 cells, both in vitro and in vivo
2013
·
C.‐Y. Li
, Y. Wang
, et al.
·
Cell Proliferation
·
16
A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge
2024
·
Yuying Tian
, Zhuoya Deng
, et al.
·
Virology
·
15
An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma
2024
·
Hao Yang
, Guanglin Lei
, et al.
·
Journal of Hepatocellular Carcinoma
·
5
PDF
Abstract LB427: The MTA-cooperative PRMT5 inhibitor ABSK131 exhibits potent activity and broad synergistic potential in MTAP-deleted cancer models
2025
·
Bin Shen
, Qianqian Chen
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
5
Citation count:
54
H-index:
4
I10-index:
3
Year
Topic
Type